Bladder Cancer, Robot-assisted Radical Cystectomy
Conditions
Brief summary
A multicenter, retrospective research was conducted. Patients who underwent robot-assisted radical cystectomy (RARC) from for bladder cancer in 32 institutions in China were enrolled in this study. Baseline condition, perioperative, pathological, and survival outcome were collected. The study was aimed to report the real-world condition of RARC in China, and evaluate its effectiveness.
Interventions
PROCEDURERobot-assisted radical cystectomy
Robot-assisted radical cystectomy
Sponsors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* \>18 years old; Clinical stage Ta-T4a/N0-3/M0.
Exclusion criteria
* Severe cardiovascular disease; history of previous major abdominopelvic surgery; patients with distant metastases; medical history of malignancy in other organs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | Five years | Time from surgery until death from any cause |
| Recurrence-free survival | Five years | Time from surgery to tumor recurrence which identified either pathologically or radiographically |
| Cancer-specific survival | Five years | Time from date of surgery to death due to bladder cancer |
Contacts
Primary ContactJian Huang, MD
Outcome results
None listed